NewsThe GuardianMay 5, 2026United States
Abortion Pills Remain Accessible After Supreme Court Intervention in Legal Challenge
Following the overturning of Roe v. Wade, access to abortion pills, particularly mifepristone, has become a central battleground. A recent legal challenge by Louisiana sought to restrict nationwide access to mifepristone via mail and telehealth, but the Supreme Court temporarily blocked the order, preserving current access for now. Despite political shifts, the anti-choice movement continues efforts to restrict abortion access, while abortion pills remain a key method for accessing care, even in states with bans.
Read the full story at The GuardianWhy It Matters
This document explains how ongoing legal battles and Supreme Court decisions are impacting access to essential reproductive healthcare, affecting millions of women across the United States.
Key Facts
- The Supreme Court's Dobbs decision in 2022 overturned Roe v. Wade, impacting abortion policy nationwide.
- A lawsuit, Louisiana v FDA, challenged nationwide access to the abortion drug mifepristone via mail and telehealth.
- The fifth circuit court of appeals initially banned mifepristone distribution, but the Supreme Court temporarily blocked this order.
- Mifepristone, used in over 60% of US abortions, is crucial for accessing care, especially in states with bans.
- Despite legal challenges, abortion pills remain accessible for now due to Supreme Court intervention and alternative strategies by providers.